North America |
USA1
|
0 |
|
USA2
|
20.2 |
South America |
Brazil3
|
12 |
|
Brazil28
|
12 (41% of these caused by P. aeruginosa) |
Europe |
UK29
|
6 (1995–1998); 15 (2004–2007) |
|
UK4
|
12 |
|
UK5
|
21 |
|
UK6
|
28.5 (24.3% of total cases caused by P. aeruginosa) |
|
UK30
|
20.9 |
|
Ireland7
|
33.3 (56.2 of CLMK) |
|
The Netherlands8
|
22.4 |
|
Turkey9
|
6.6 (Pseudomonas sp.) |
|
Italy10
|
72.2 |
Middle East |
Iraq31
|
42 (100% of those associated with contact lenses caused by Pseudomonas sp.) |
|
Kingdom of Bahrain32
|
54 (95% of those associated with contact lenses caused by P. aeruginosa) |
|
Various27 (predominantly Iraq) |
71 |
|
Oman33
|
28.8 (all CLMK) |
Africa |
Sierra Leone34
|
40 |
|
Nigeria35
|
22.4 |
Indian subcontinent |
India36
|
71 (only cases of CLMK examined, all Pseudomonas species were P. aeruginosa) |
|
India37
|
52 |
|
India11
|
1 |
|
India12
|
24.4 |
Asia |
Japan38
|
2.8 |
|
Japan18
|
20 |
|
Japan13
|
1 |
|
Thailand16
|
59 |
|
Thailand17
|
55 |
|
Malaysia15
|
58.6 |
|
Hong Kong39
|
42.9 (85.7 of culture proven) for CLMK |
|
China40
|
20.07 |
|
Taiwan41
|
47 |
Australasia |
New Zealand42
|
3.4 (all P. aeruginosa) |
|
Australia43
|
8 |
|
Australia21
|
17 (55% of these caused by P. aeruginosa) |
|
Australia44
|
35 (CLMK; 49.2 of culture proven cases) |